Pablo Antonio Sánchez Salcedo-rekin lankidetzan egindako argitalpenak (10)

2020

  1. Prevalence and burden of bronchiectasis in a lung cancer screening program

    PLoS ONE, Vol. 15, Núm. 4

2019

  1. Emphysema phenotypes and lung cancer risk

    PLoS ONE, Vol. 14, Núm. 7

2017

  1. Clinical Features of Smokers With Radiological Emphysema But Without Airway Limitation

    Chest, Vol. 151, Núm. 2, pp. 358-365

  2. Telomere length, COPD and emphysema as risk factors for lung cancer

    European Respiratory Journal

2016

  1. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT

    Lung Cancer, Vol. 97, pp. 81-86

  2. The neutrophil to lymphocyte and platelet to lymphocyte ratios as biomarkers for lung cancer development

    Lung Cancer, Vol. 97, pp. 28-34

2015

  1. COPD comorbidities network

    European Respiratory Journal, Vol. 46, Núm. 3, pp. 640-650

  2. Improving selection criteria for lung cancer screening: The potential role of emphysema

    American Journal of Respiratory and Critical Care Medicine, Vol. 191, Núm. 8, pp. 924-931

  3. Lung Cancer Screening: Fourteen Year Experience of the Pamplona Early Detection Program (P-IELCAP)

    Archivos de Bronconeumologia, Vol. 51, Núm. 4, pp. 169-176

  4. Lung cancer in patients with chronic obstructive pulmonary disease: Development and validation of the COPD lung cancer screening score

    American Journal of Respiratory and Critical Care Medicine, Vol. 191, Núm. 3, pp. 285-291